ES482156A1 - Un procedimiento para la preparacion de nuevos derivados de-fenetanolamina. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de-fenetanolamina.

Info

Publication number
ES482156A1
ES482156A1 ES482156A ES482156A ES482156A1 ES 482156 A1 ES482156 A1 ES 482156A1 ES 482156 A ES482156 A ES 482156A ES 482156 A ES482156 A ES 482156A ES 482156 A1 ES482156 A1 ES 482156A1
Authority
ES
Spain
Prior art keywords
phenethanolamines
formulations
preparation
methylaminocarbonyl
aminocarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES482156A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES482156A1 publication Critical patent/ES482156A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/06—Preparation of carboxylic acid nitriles from N-formylated amino compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms

Abstract

Procedimientos para la preparación de nuevos derivados de fenetanolamina, útiles para controlar el peso de los mamíferos. Se han realizado extensas investigaciones en el campo de los derivados de beta-feniletilamina, como las catecolaminas. Por ejemplo, se ha estudiado mucho la catecolamina natural, epinefrina. La epinefrina es un potente fármaco simpatomimético y un intenso estimulante cardiaco. Sin embargo, el uso de la epinefrina es limitado debido a sus efectos secundarios indeseables entre los que se encuentran temor, ansiedad, temblores, tensión nerviosa, dolores de cabeza con latidos, mayor presión sanguínea, vértigos, dificultades respiratorias y palpitaciones así como debido a su corta duración de acción.
ES482156A 1978-07-03 1979-07-03 Un procedimiento para la preparacion de nuevos derivados de-fenetanolamina. Expired ES482156A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92167078A 1978-07-03 1978-07-03

Publications (1)

Publication Number Publication Date
ES482156A1 true ES482156A1 (es) 1980-08-16

Family

ID=25445792

Family Applications (4)

Application Number Title Priority Date Filing Date
ES482155A Expired ES482155A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de derivados de feneta-nolamina.
ES482156A Expired ES482156A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de nuevos derivados de-fenetanolamina.
ES490215A Expired ES8104190A1 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina
ES490214A Expired ES8104189A1 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES482155A Expired ES482155A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de derivados de feneta-nolamina.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES490215A Expired ES8104190A1 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina
ES490214A Expired ES8104189A1 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina

Country Status (31)

Country Link
EP (3) EP0048037A1 (es)
JP (2) JPS559097A (es)
KR (1) KR880002310B1 (es)
AR (4) AR225744A1 (es)
AT (2) AT367025B (es)
AU (2) AU523720B2 (es)
BE (2) BE877393A (es)
BG (4) BG31646A3 (es)
CA (2) CA1142954A (es)
CH (2) CH643529A5 (es)
CS (4) CS208662B2 (es)
DD (2) DD144761A5 (es)
DE (2) DE2964604D1 (es)
DK (2) DK160936C (es)
EG (1) EG14238A (es)
ES (4) ES482155A1 (es)
FI (2) FI792082A (es)
FR (3) FR2430410B1 (es)
GB (3) GB2028799B (es)
GR (2) GR72940B (es)
HU (2) HU179172B (es)
IE (2) IE48769B1 (es)
IL (2) IL57671A (es)
LU (2) LU81457A1 (es)
NZ (2) NZ190861A (es)
PH (2) PH14522A (es)
PL (4) PL121297B1 (es)
PT (2) PT69843A (es)
RO (4) RO83052B (es)
SU (4) SU849997A3 (es)
ZA (2) ZA793297B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
EP0028105B1 (en) * 1979-10-25 1983-01-19 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
EP0029320B1 (en) * 1979-11-15 1985-07-10 Beecham Group Plc Secondary ethanol amines, their preparation and their use in pharmaceutical compositions
DE3161165D1 (en) * 1980-05-08 1983-11-17 Beecham Group Plc Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions
DE3264364D1 (en) * 1981-03-06 1985-08-01 Beecham Group Plc Arylethanol amine derivatives, their preparation and use in pharmaceutical compositions
DE3260490D1 (en) * 1981-03-31 1984-09-06 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
EP0070133B1 (en) * 1981-07-11 1986-05-14 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
EP0089154A3 (en) * 1982-03-12 1984-08-08 Beecham Group Plc Ethanolamine derivatives, their preparation and use in pharmaceutical compositions
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
JPS5980640A (ja) * 1982-09-27 1984-05-10 イーライ・リリー・アンド・カンパニー ２−ヒドロキシ−２−フエニルエチルアミン類の製造方法
PL144053B1 (en) * 1983-01-31 1988-04-30 Lilly Co Eli Method of stimulating growth of domesticated animals,improving effectivness of food utilization ba domesticated animals and improving leanness of domesticated animals and fodder pre-mixture
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
US4602044A (en) * 1983-12-19 1986-07-22 Eli Lilly And Company β-phenethanolamine antiobesity agents
EP0151513A1 (en) * 1984-01-12 1985-08-14 Eli Lilly And Company Inotropic agent
GB8505284D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Growth promoters
PT82120B (en) * 1985-03-01 1988-06-16 Beecham Group Plc Process for preparing veterinary formulations containing ethanolamine derivatives
IT1204416B (it) * 1986-06-27 1989-03-01 Midy Spa Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini
JP2837408B2 (ja) * 1987-05-30 1998-12-16 鐘紡株式会社 アクリル系繊維の処理方法
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
FI892341A (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanolaminderivat.
US5191112A (en) * 1989-10-17 1993-03-02 Nissan Chemical Industries, Ltd. Process for optical resolution of (±)-2-(3-benzoyl)-phenylpropionic acid
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
KR100251995B1 (ko) * 1991-08-23 2000-06-01 젠센 제임스 유. 칼슘 수용체 활성 분자
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
CN1312116C (zh) 1994-10-21 2007-04-25 Nps药物有限公司 钙受体活性化合物
DE69722934T2 (de) 1996-05-01 2004-05-27 NPS Pharmaceuticals, Inc., Salt Lake City Verbindungen , die auf anorganische ionen-rezeptoren wirken
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL56308C (es) * 1941-03-15
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1301134A (en) 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
BE788850A (fr) * 1972-09-15 1973-03-15 Hoffmann La Roche Derives d'acide benzoique
IE39247B1 (en) * 1973-05-07 1978-08-30 Allen & Hanburys Ltd Substituted benzamides
US4000192A (en) * 1973-05-07 1976-12-28 Allen & Hanburys Limited Pharmacologically active compounds
NZ190854A (en) * 1978-06-28 1984-10-19 Beecham Group Ltd 2-hydroxy-2-phenyl ethylamine derivatives;pharmaceutical compositions
CA1145766A (en) * 1978-07-03 1983-05-03 Jack Mills Optically active phenethanolamines and method for increasing cardiac contractility

Also Published As

Publication number Publication date
AU4848779A (en) 1980-01-10
FI792081A (fi) 1980-01-04
ATA463579A (de) 1983-04-15
AU4848979A (en) 1980-01-10
IE791228L (en) 1980-01-03
SU1007554A3 (ru) 1983-03-23
NZ190863A (en) 1982-05-25
GB2028799A (en) 1980-03-12
HU179172B (en) 1982-08-28
GB2028799B (en) 1982-09-08
BE877393A (fr) 1980-01-02
AU523721B2 (en) 1982-08-12
ZA793296B (en) 1981-02-25
RO83051B (ro) 1984-02-28
SU957761A3 (ru) 1982-09-07
AT367025B (de) 1982-05-25
BG31645A3 (en) 1982-02-15
SU849997A3 (ru) 1981-07-23
AR229080A1 (es) 1983-06-15
DE2964091D1 (en) 1982-12-30
FR2450806B1 (fr) 1985-07-12
ES490215A0 (es) 1981-04-16
ES490214A0 (es) 1981-04-16
ES482155A1 (es) 1980-08-16
BG31375A3 (en) 1981-12-15
FR2430410A1 (fr) 1980-02-01
RO77732A (ro) 1981-11-24
RO83051A (ro) 1984-02-21
IL57672A (en) 1983-03-31
GB2101582A (en) 1983-01-19
IE48586B1 (en) 1985-03-20
FR2430411B1 (es) 1983-08-19
PL117551B1 (en) 1981-08-31
ZA793297B (en) 1981-02-25
CH642618A5 (fr) 1984-04-30
CS208663B2 (en) 1981-09-15
ES8104189A1 (es) 1981-04-16
EP0007204A1 (en) 1980-01-23
CS209815B2 (en) 1981-12-31
EG14238A (en) 1983-12-31
EP0006766A1 (en) 1980-01-09
KR880002310B1 (ko) 1988-10-22
KR830001187A (ko) 1983-04-29
JPS6254095B2 (es) 1987-11-13
PH15275A (en) 1982-11-02
AR231434A1 (es) 1984-11-30
DE2964604D1 (en) 1983-03-03
BE877394A (fr) 1980-01-02
RO83052B (ro) 1984-02-28
RO83052A (ro) 1984-02-21
PL121297B1 (en) 1982-04-30
ATA463679A (de) 1981-10-15
PT69843A (en) 1979-07-01
ES8104190A1 (es) 1981-04-16
DD144761A5 (de) 1980-11-05
JPS559097A (en) 1980-01-22
PL117997B1 (en) 1981-09-30
LU81458A1 (fr) 1979-10-30
GR74524B (es) 1984-06-29
FI792082A (fi) 1980-01-04
IL57671A (en) 1982-11-30
CS208664B2 (en) 1981-09-15
PT69839A (en) 1979-07-01
DD144762A5 (de) 1980-11-05
CA1142954A (en) 1983-03-15
IE791227L (en) 1980-01-03
EP0006766B1 (en) 1983-01-26
GB2101582B (en) 1983-06-08
AR225744A1 (es) 1982-04-30
BG31646A3 (en) 1982-02-15
CH643529A5 (fr) 1984-06-15
AU523720B2 (en) 1982-08-12
AT372937B (de) 1983-11-25
LU81457A1 (fr) 1979-10-30
DK160936C (da) 1991-10-21
FR2450806A1 (fr) 1980-10-03
DK268779A (da) 1980-01-04
GB2028802B (en) 1983-03-30
CS208662B2 (en) 1981-09-15
EP0048037A1 (en) 1982-03-24
DK160936B (da) 1991-05-06
BG31647A3 (en) 1982-02-15
RO77728A (ro) 1981-11-24
AR227165A1 (es) 1982-09-30
IE48769B1 (en) 1985-05-15
GR72940B (es) 1984-01-16
PL117996B1 (en) 1981-09-30
DK268679A (da) 1980-01-04
FR2430410B1 (fr) 1986-03-21
FR2430411A1 (fr) 1980-02-01
PL216814A1 (es) 1980-03-24
JPS559096A (en) 1980-01-22
NZ190861A (en) 1981-12-15
IL57671A0 (en) 1979-10-31
IL57672A0 (en) 1979-10-31
HU179171B (en) 1982-08-28
CA1145767A (en) 1983-05-03
PH14522A (en) 1981-08-26
EP0007204B1 (en) 1982-11-24
GB2028802A (en) 1980-03-12
PL216811A1 (es) 1980-08-25
SU965350A3 (ru) 1982-10-07

Similar Documents

Publication Publication Date Title
ES482155A1 (es) Un procedimiento para la preparacion de derivados de feneta-nolamina.
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
GR3003267T3 (en) 1-phenyl-3-naphthalenyloxy-propanamines
EP0034473A3 (en) Substituted imidazoles, their preparation, pharmaceutical compositions containing the same and their use in therapy
EP0265514A4 (en) Drugs for the inhibition of ridicule.
ES8105265A1 (es) Un procedimiento para la preparacion de fenetanolaminas
ES482153A1 (es) Un procedimiento para preparar nuevas fenetanolaminas.
DE3170937D1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
ES8609286A1 (es) Un metodo para preparar un compuesto de morfolinol
ES2000587A6 (es) Un procedimiento para preparar derivados de piridil-alquil-imidazol
ES8700242A1 (es) Un procedimiento para preparar un derivado de dihidropirida-zinona
NO883262D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
ES474367A1 (es) Procedimiento de preparacion de nuevos derivados del benzo- (d)tiazol.
ES8305758A1 (es) "un procedimiento para la preparacion de 2-(1,4-benzodioxan-2-il-metil)-imidazolina".
ES8205804A1 (es) Un procedimiento para la preparacio,n de nuevos derivados de denzopirano 2,3-d-v-triazol.
ES8304956A1 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
DE3166665D1 (en) Dibenzocycloheptenylidenes and their use in pharmaceutical compositions
JPS5430167A (en) 4-aminomethyl-2-phenyloxazoles and their pharmaceutically acceptable acid salts
ES8202811A1 (es) Un procedimiento para la preparacion de derivados de benzo (1,4) dioxina
ES8300709A1 (es) Un metodo para la preparacion de derivados de pirazolidinona
JPS5414961A (en) Novel 3-hydroxyazetidine-3-carboxylic derivative